Bristol-Myers Squibb Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance
July 25, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.18, $0.12 better than the analyst estimate of $1.06. Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.20-$4.30, versus the consensus of... More
